Amgen Inc vs. C4 Therapeutics, Inc.
Amgen Inc (AMGN) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| AMGN | CCCC | |
|---|---|---|
| Market Cap | $208.49 billion | $417.06 million |
| Revenue (TTM) | $38.09 billion | $35.04 million |
| Net Income (TTM) | $8.74 billion | $-101,416,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | CCCC | |
|---|---|---|
| P/E Ratio | 24.35 | — |
| Price / Book | 17.84 | 1.69 |
| Price / Sales | 5.47 | 11.90 |
AMGN and CCCC split the valuation factors evenly.
Profitability
| AMGN | CCCC | |
|---|---|---|
| Net Margin | 22.95% | -289.44% |
| Return on Equity | 74.80% | -41.02% |
AMGN leads on 2 of 2 profitability factors.
Dividend
| AMGN | CCCC | |
|---|---|---|
| Dividend Yield | 2.57% | — |
| Payout Ratio | 62.61 | — |
AMGN and CCCC split the dividend factors evenly.
Risk & Sentiment
| AMGN | CCCC | |
|---|---|---|
| Short Interest | 1.66% | 0.29% |
CCCC leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, CCCC overview, CCCC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.